V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220018939 | 220006171 | 1.59 | 48.5 | Curative (C) | 2019-04-30 | 2019-04-30 | FLAG + Idarubicin | 2 | N | 220023414 | FLAG + IDARUBICIN |
| 220018940 | 220006172 | 1.57 | 77.6 | Curative (C) | 2016-11-20 | 2017-01-24 | AML17 TRIAL | N | N | 220023416 | AML17 TRIAL |
| 220018941 | 220006175 | 1.66 | 86 | Curative (C) | 2014-01-01 | 2014-01-01 | AML17 TRIAL | N | N | 220023455 | AML17 TRIAL |
| 220018942 | 220006178 | 1.73 | 28.85 | Curative (C) | 2015-10-20 | 2015-10-28 | FLAG + Idarubicin | N | N | 220023465 | FLAG + IDARUBICIN |
| 220018943 | 220019482 | 1.78 | 95 | Curative (C) | 2017-08-29 | 2017-12-19 | AML17 TRIAL | null | N | 220023471 | AML17 TRIAL |
| 220018944 | 220006183 | 1.61 | 73.8 | Not known (9) | 2016-09-26 | 2016-10-02 | FLAG + Idarubicin | 02 | N | 220023478 | FLAG + IDARUBICIN |
| 220018945 | 220006188 | null | null | Curative (C) | null | 2018-05-18 | FLAG + Idarubicin | 02 | N | 220023489 | FLAG + IDARUBICIN |
| 220018946 | 220013324 | 1.61 | 82 | Palliative (P) | 2017-01-12 | 2017-01-12 | FLAG + Idarubicin | Y | N | 220023497 | FLAG + IDARUBICIN |
| 220018947 | 220006196 | 1.77 | null | Curative (C) | 2016-03-21 | 2016-06-08 | AML17 TRIAL | N | N | 220023499 | AML17 TRIAL |
| 220018948 | 220006198 | 1.76 | 79.4 | Palliative (P) | null | 2014-04-07 | FLAG + Idarubicin | 02 | null | 220023517 | FLAG + IDARUBICIN |
| 220018949 | 220006199 | null | 84 | Adjuvant (A) | 2014-04-25 | 2014-04-25 | AML17 TRIAL | 02 | N | 220023525 | AML17 TRIAL |
| 220018950 | 220006203 | 1.76 | 75.1 | Adjuvant (A) | null | 2014-11-13 | FLAG + Idarubicin | null | N | 220023551 | FLAG + IDARUBICIN |
| 220018951 | 220017298 | 1.84 | null | Palliative (P) | null | 2017-10-17 | AML17 TRIAL | null | N | 220023564 | AML17 TRIAL |
| 220018953 | 220006214 | 1.77 | 128.3 | Curative (C) | 2015-12-10 | 2016-03-17 | AML17 TRIAL | N | N | 220023606 | AML17 TRIAL |
| 220018954 | 220006218 | 1.53 | 87 | Curative (C) | 2012-09-28 | 2012-09-28 | AML17 TRIAL | N | N | 220023614 | AML17 TRIAL |
| 220018955 | 220006220 | 1.7 | 61.1 | Adjuvant (A) | 2013-10-21 | 2013-10-21 | AML17 TRIAL | N | N | 220023620 | AML17 TRIAL |
| 220018956 | 220006222 | 1.76 | 68 | Curative (C) | 2017-04-20 | 2017-06-06 | AML17 TRIAL | null | N | 220023625 | AML17 TRIAL |
| 220018957 | 220006225 | 1.72 | 65.6 | Curative (C) | null | 2015-08-17 | FLAG + Idarubicin | N | N | 220023640 | FLAG + IDARUBICIN |
| 220018958 | 220006228 | 1.73 | 88.8 | Not known (9) | 2013-11-02 | 2013-11-05 | AML17 TRIAL | Y | N | 220023646 | AML17 TRIAL |
| 220018959 | 220006233 | null | null | Disease modification (D) | 2016-02-06 | 2016-02-06 | AML17 TRIAL | N | N | 220023647 | AML17 TRIAL |
| 220018960 | 220013352 | 1.88 | 77.6 | Palliative (P) | 2016-12-22 | 2016-12-31 | Trial Unspecified | N | N | 220023662 | TRIAL |
| 220018961 | 220006237 | 1.83 | 81.1 | Disease modification (D) | 2014-01-30 | 2014-02-03 | Trial Unspecified | N | null | 220023671 | TRIAL |
| 220018962 | 220006240 | 1.66 | 62.1 | Curative (C) | 2016-11-06 | 2016-11-06 | AML 19 TRIAL | 2 | N | 220023676 | AML19 TRIAL |
| 220018963 | 220006243 | 1.57 | null | Curative (C) | 2013-11-03 | 2014-01-15 | Trial Unspecified | Y | N | 220023681 | TRIAL |
| 220018964 | 220006244 | 1.59 | 58.5 | Curative (C) | 2015-11-26 | 2015-11-30 | Trial Unspecified | 01 | N | 220023691 | TRIAL |
| 220018965 | 220006247 | 1.71 | 70.3 | Curative (C) | 2016-09-28 | 2016-09-30 | Trial Unspecified | 1 | N | 220023701 | TRIAL |
| 220018966 | 220006256 | 1.62 | 122 | Curative (C) | 2013-01-17 | 2013-06-30 | Trial Unspecified | Y | N | 220023737 | TRIAL |
| 220018967 | 220017311 | 1.6 | 79.4 | Curative (C) | 2014-07-24 | 2014-07-27 | AML 19 TRIAL | null | N | 220023739 | AML19 TRIAL |
| 220018969 | 220006263 | 1.78 | 100.5 | Curative (C) | 2015-06-10 | 2015-07-23 | AML 19 TRIAL | Y | N | 220023759 | AML19 TRIAL |
| 220018970 | 220006267 | 1.49 | 72 | Curative (C) | 2016-07-07 | 2016-12-17 | AML 19 TRIAL | N | null | 220023778 | AML19 TRIAL |
| 220018971 | 220006270 | 1.64 | 60 | Curative (C) | 2013-08-08 | 2013-09-11 | Trial Unspecified | Y | N | 220023787 | TRIAL |
| 220018972 | 220006271 | 1.77 | 73.3 | Palliative (P) | 2013-08-06 | 2013-08-09 | AML 19 TRIAL | 01 | N | 220023793 | AML19 TRIAL |
| 220018973 | 220006276 | 1.63 | 60.2 | null | 2014-11-05 | 2014-11-05 | Trial Unspecified | Y | null | 220023811 | TRIAL |
| 220018974 | 220006281 | 1.74 | 64.4 | Curative (C) | 2017-04-22 | 2017-08-12 | AML 19 TRIAL | Y | N | 220023821 | AML19 TRIAL |
| 220018975 | 220006284 | 1.8 | 102.6 | Curative (C) | 2016-07-21 | 2016-10-12 | AML 19 TRIAL | Y | N | 220023828 | AML19 TRIAL |
| 220018977 | 220006287 | null | null | Curative (C) | 2014-10-15 | 2014-10-17 | Trial Unspecified | Y | N | 220023833 | TRIAL |
| 220018978 | 220006295 | 1.72 | 71.1 | Disease modification (D) | 2017-02-11 | 2017-02-11 | AML 19 TRIAL | Y | null | 220023866 | AML19 TRIAL |
| 220018979 | 220006300 | 1.6 | 92 | Curative (C) | 2017-11-04 | 2017-11-08 | AML 19 TRIAL | Y | N | 220023873 | AML19 TRIAL |
| 220018980 | 220006301 | 1.72 | 78.8 | Curative (C) | 2017-05-25 | 2017-05-25 | Trial Unspecified | 02 | null | 220023877 | TRIAL |
| 220018981 | 220006306 | 1.67 | 53.4 | Curative (C) | 2017-12-20 | 2017-12-20 | Trial Unspecified | N | N | 220023893 | TRIAL |
| 220018982 | 220006308 | 1.71 | 64.8 | Curative (C) | 2013-10-29 | 2014-01-06 | Trial Unspecified | Y | null | 220023897 | TRIAL |
| 220018983 | 220006312 | 1.83 | null | Curative (C) | 2018-08-16 | 2018-08-20 | Trial Unspecified | 02 | N | 220023923 | TRIAL |
| 220018984 | 220006313 | 1.72 | 79.8 | null | 2019-04-30 | 2019-05-12 | Trial Unspecified | N | N | 220023932 | TRIAL |
| 220018985 | 220006315 | 1.79 | 61.05 | Curative (C) | 2014-02-19 | 2014-04-22 | AML 19 TRIAL | N | N | 220023933 | AML19 TRIAL |
| 220018986 | 220006316 | 1.8 | 102.6 | Curative (C) | 2017-01-20 | 2017-01-25 | AML 19 TRIAL | N | Y | 220023938 | AML19 TRIAL |
| 220018987 | 220006319 | 1.72 | 76.3 | Curative (C) | 2017-06-18 | 2017-07-31 | Trial Unspecified | Y | N | 220023939 | TRIAL |
| 220018988 | 220006322 | 1.8 | 100 | Curative (C) | 2017-06-17 | 2017-06-23 | Trial Unspecified | 1 | N | 220023967 | TRIAL |
| 220018989 | 220006326 | 1.69 | 84.7 | Curative (C) | 2019-06-27 | 2019-07-01 | Trial Unspecified | 01 | N | 220023982 | TRIAL |
| 220018990 | 220006328 | 1.59 | 52.6 | Curative (C) | 2017-11-26 | 2017-12-05 | AML 19 TRIAL | Y | N | 220023988 | AML19 TRIAL |
| 220018991 | 220013421 | 1.7 | 81.4 | Curative (C) | 2016-04-25 | 2016-08-12 | AML 19 TRIAL | Y | null | 220024000 | AML19 TRIAL |